TY - JOUR
T1 - KATP channels
T2 - From structure to disease
AU - Nichols, C. G.
AU - Koster, J.
AU - Enkvetchakul, D.
AU - Flagg, T.
PY - 2006/12/18
Y1 - 2006/12/18
N2 - ATP-sensitive K+-channels (KATP) provide a unique link between cell metabolism and excitability in multiple organs and cell types. In smooth muscle, for instance, activation of KATP channels causes vasodilation. In the pancreatic β-cell, they play an essential role in coupling membrane excitability with glucose-stimulated insulin secretion (GSIS). Sulfonylureas, hypoglycemic agents used in the treatment of type 2 diabetes, act by binding to the regulatory SUR1 subunit and inhibiting KATP current, leading to depolarization, Ca2+ entry and insulin secretion. By contrast, KATP-specific channel openers, diazoxide and pinacidil, suppress insulin release and cause lowering of blood pressure, by activating KATP and preventing depolarization-dependent rise in [Ca 2+]i. In the heart, activation of KATP causes action potential shortening in ischemia, and underlies a cardioprotective effect by reducing Ca2+ entry. Over the last few years, significant advances have been made in understanding the molecular basis of channel activity and the role of these channels in physiology and diseases. This mini-review will highlight these advances and point out challenges that will face the next phase of understanding.
AB - ATP-sensitive K+-channels (KATP) provide a unique link between cell metabolism and excitability in multiple organs and cell types. In smooth muscle, for instance, activation of KATP channels causes vasodilation. In the pancreatic β-cell, they play an essential role in coupling membrane excitability with glucose-stimulated insulin secretion (GSIS). Sulfonylureas, hypoglycemic agents used in the treatment of type 2 diabetes, act by binding to the regulatory SUR1 subunit and inhibiting KATP current, leading to depolarization, Ca2+ entry and insulin secretion. By contrast, KATP-specific channel openers, diazoxide and pinacidil, suppress insulin release and cause lowering of blood pressure, by activating KATP and preventing depolarization-dependent rise in [Ca 2+]i. In the heart, activation of KATP causes action potential shortening in ischemia, and underlies a cardioprotective effect by reducing Ca2+ entry. Over the last few years, significant advances have been made in understanding the molecular basis of channel activity and the role of these channels in physiology and diseases. This mini-review will highlight these advances and point out challenges that will face the next phase of understanding.
UR - http://www.scopus.com/inward/record.url?scp=33845428562&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33845428562
SN - 0233-4755
VL - 23
SP - 101
EP - 110
JO - Biologicheskie Membrany
JF - Biologicheskie Membrany
IS - 2
ER -